Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnancy Antihypertensive Drugs: Which Agent Is Best?
2020-003410-12Phase 4Unknown
- Sponsor
- University of Birmingham
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pregnancy-induced hypertension (PIH), hypertension (HTN) and preeclampsia comparing Labetalol arm with Nifedipine arm (2 arms). Primary endpoint: Maternal severe hypertension. Status: unknown.
02
Drugs
labetalolnifedipine
03
Conditions
pregnancy-induced hypertension (PIH)hypertension (HTN)preeclampsia
Beyond the preview
Go deeper on 2020-003410-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003410-12.